Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

Is This GlaxoSmithKline's Next Big Blockbuster?
Motley Fool
Fri, 06/7/13 - 05:47 pm
Tags:
rheumatoid arthritis, GSK, Humira, AbbVie, MOR103, MorphoSys
AbbVie Ups Ante on JAK Inhibitor
Motley Fool
Sat, 06/1/13 - 12:21 pm
Tags:
AbbVie, rheumatoid arthritis, JAK inhibitors
The Race For Oral HCV?
Seeking Alpha
Fri, 05/31/13 - 12:57 pm
Tags:
AbbVie, Gilead, JNJ, Merck, Vertex Pharmaceuticals, hepatitis C
AbbVie Price Boost of Drug Slammed in Studies Criticized
Bloomberg
Thu, 05/23/13 - 10:43 am
Tags:
drug pricing, AbbVie, Niaspan
The 5 Highest-Paying Dividend Stocks in Big Pharma
Motley Fool
Wed, 05/22/13 - 11:51 am
Tags:
dividends, AbbVie, Eli Lilly, Merck, GSK, AstraZeneca
[video]AbbVie's New Crohn's Disease Drug Candidate
Motley Fool
Tue, 05/21/13 - 10:06 am
Tags:
AbbVie, Crohn's Disease, JAK inhibitors, Galapagos
AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
Yahoo
Mon, 05/20/13 - 11:21 am
Tags:
diabetic neuropathy, AbbVie, atrasentan
AbbVie's Latest Drug Deal Marks A Shift In The Celiac Disease Therapeutics Field
Seeking Alpha
Mon, 05/20/13 - 11:20 am
Tags:
AbbVie, celiac disease, BioLineRx, Alvine, AVL003
AbbVie Investors, Watch This Management Change (video)
Motley Fool
Sun, 05/19/13 - 11:20 am
Tags:
AbbVie
AbbVie and Galapagos extend GLPG0634 collaboration to include Crohn's disease
Yahoo/Reuters
Fri, 05/17/13 - 10:43 am
Tags:
Galapagos, AbbVie, GLPG0634, Crohn's Disease
Celgene: Apremilast For Psoriatic Arthritis Offers Upside
Seeking Alpha
Tue, 05/14/13 - 05:22 pm
Tags:
apremilast, psoriatic arthritis, Celgene, AbbVie, Amgen, JNJ, Remicade, Enbrel, Humira
A Culture Change? AbbVie R&D Chief To Retire
Pharmalot
Tue, 05/14/13 - 10:14 am
Tags:
AbbVie, R&D
AbbVie and Alvine to Collaborate on Investigational Oral Therapy for Celiac Disease
Yahoo
Tue, 05/14/13 - 09:26 am
Tags:
AbbVie, Alvine, celiac disease, ALV003
AbbVie, Pfizer's Zoetis deals ignite enormous leap in M&A value
Fierce Pharma
Mon, 05/13/13 - 12:26 pm
Tags:
AbbVie, Pfizer, Zoetis, M&A, Abbott Laboratories
Covidien Aiming For Mallinckrodt Spin-Out
Seeking Alpha
Wed, 05/8/13 - 04:22 pm
Tags:
Covidien, Mallinckrodt, spin-offs, AbbVie, devices
The pharma spin-offs have just begun, bankers figure
Fierce Pharma
Wed, 05/8/13 - 10:56 am
Tags:
spin-offs, Sanofi, GSK, Abbott Laboratories, AbbVie
3 Bio Companies Facing The Patent Cliff
Seeking Alpha
Tue, 05/7/13 - 05:31 pm
Tags:
patents, patent cliff, AbbVie, BiogenIdec, Eisai, JNJ, Eli Lilly, Novartis, Sanofi, Roche
FDA ‘breakthrough’ tab on AbbVie Hepatitis C drug leaves shares flat
Marketwatch
Mon, 05/6/13 - 11:34 am
Tags:
FDA, breakthrough therapies, hepatitis C, AbbVie
The New Abbott Labs Is Leaner, but Needs Better Execution
TheStreet.com
Fri, 05/3/13 - 08:49 am
Tags:
Abbott Laboratories, AbbVie, JNJ
AbbVie Earnings Call Nuggets: Growth Guidance and Drug Candidates
Wall Street Cheat Street
Sun, 04/28/13 - 12:21 pm
Tags:
AbbVie, earnings

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.